Intraperitoneal collagenase as a novel therapeutic approach in an experimental model of colorectal peritoneal carcinomatosis

Abstract The usefulness of local collagenase in therapeutic approaches to solid tumors has been tested recently. In this study, we evaluate the safety and efficacy of intraperitoneal collagenase associated or not to mitomycin for treatment of colorectal peritoneal metastases in an experimental rat m...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: D. García-Olmo, P. Villarejo Campos, J. Barambio, S. Garcia Gomez-Heras, L. Vega-Clemente, S. Olmedillas-Lopez, H. Guadalajara, M. Garcia-Arranz
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/4c4571ad4d8841f8bec9a3ff5ac4df1d
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:4c4571ad4d8841f8bec9a3ff5ac4df1d
record_format dspace
spelling oai:doaj.org-article:4c4571ad4d8841f8bec9a3ff5ac4df1d2021-12-02T15:22:59ZIntraperitoneal collagenase as a novel therapeutic approach in an experimental model of colorectal peritoneal carcinomatosis10.1038/s41598-020-79721-02045-2322https://doaj.org/article/4c4571ad4d8841f8bec9a3ff5ac4df1d2021-01-01T00:00:00Zhttps://doi.org/10.1038/s41598-020-79721-0https://doaj.org/toc/2045-2322Abstract The usefulness of local collagenase in therapeutic approaches to solid tumors has been tested recently. In this study, we evaluate the safety and efficacy of intraperitoneal collagenase associated or not to mitomycin for treatment of colorectal peritoneal metastases in an experimental rat model. Using a fixed-dose procedure, we found that a dose of collagenase of 37 IU/mL administered for 15 min with a hyperthermia pump at 37.5 °C, both in isolation or associated to sequential treatment with intraperitoneal mitomycin, led to a macroscopic decrease in tumor volume as evaluated by the modified peritoneal cancer index (mPCI). Concerning the safety of the procedure, the animals showed no physiological or behavioral disorders during 8 weeks of follow-up. Local treatment for peritoneal metastases of colorectal origin with intraperitoneal collagenase has proved safe and effective in an experimental murine model. Therefore, the stroma-first approach by enzymatic breakdown of collagen from the tumor's extracellular matrix provides a new therapeutic target for colorectal peritoneal metastases.D. García-OlmoP. Villarejo CamposJ. BarambioS. Garcia Gomez-HerasL. Vega-ClementeS. Olmedillas-LopezH. GuadalajaraM. Garcia-ArranzNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-8 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
D. García-Olmo
P. Villarejo Campos
J. Barambio
S. Garcia Gomez-Heras
L. Vega-Clemente
S. Olmedillas-Lopez
H. Guadalajara
M. Garcia-Arranz
Intraperitoneal collagenase as a novel therapeutic approach in an experimental model of colorectal peritoneal carcinomatosis
description Abstract The usefulness of local collagenase in therapeutic approaches to solid tumors has been tested recently. In this study, we evaluate the safety and efficacy of intraperitoneal collagenase associated or not to mitomycin for treatment of colorectal peritoneal metastases in an experimental rat model. Using a fixed-dose procedure, we found that a dose of collagenase of 37 IU/mL administered for 15 min with a hyperthermia pump at 37.5 °C, both in isolation or associated to sequential treatment with intraperitoneal mitomycin, led to a macroscopic decrease in tumor volume as evaluated by the modified peritoneal cancer index (mPCI). Concerning the safety of the procedure, the animals showed no physiological or behavioral disorders during 8 weeks of follow-up. Local treatment for peritoneal metastases of colorectal origin with intraperitoneal collagenase has proved safe and effective in an experimental murine model. Therefore, the stroma-first approach by enzymatic breakdown of collagen from the tumor's extracellular matrix provides a new therapeutic target for colorectal peritoneal metastases.
format article
author D. García-Olmo
P. Villarejo Campos
J. Barambio
S. Garcia Gomez-Heras
L. Vega-Clemente
S. Olmedillas-Lopez
H. Guadalajara
M. Garcia-Arranz
author_facet D. García-Olmo
P. Villarejo Campos
J. Barambio
S. Garcia Gomez-Heras
L. Vega-Clemente
S. Olmedillas-Lopez
H. Guadalajara
M. Garcia-Arranz
author_sort D. García-Olmo
title Intraperitoneal collagenase as a novel therapeutic approach in an experimental model of colorectal peritoneal carcinomatosis
title_short Intraperitoneal collagenase as a novel therapeutic approach in an experimental model of colorectal peritoneal carcinomatosis
title_full Intraperitoneal collagenase as a novel therapeutic approach in an experimental model of colorectal peritoneal carcinomatosis
title_fullStr Intraperitoneal collagenase as a novel therapeutic approach in an experimental model of colorectal peritoneal carcinomatosis
title_full_unstemmed Intraperitoneal collagenase as a novel therapeutic approach in an experimental model of colorectal peritoneal carcinomatosis
title_sort intraperitoneal collagenase as a novel therapeutic approach in an experimental model of colorectal peritoneal carcinomatosis
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/4c4571ad4d8841f8bec9a3ff5ac4df1d
work_keys_str_mv AT dgarciaolmo intraperitonealcollagenaseasanoveltherapeuticapproachinanexperimentalmodelofcolorectalperitonealcarcinomatosis
AT pvillarejocampos intraperitonealcollagenaseasanoveltherapeuticapproachinanexperimentalmodelofcolorectalperitonealcarcinomatosis
AT jbarambio intraperitonealcollagenaseasanoveltherapeuticapproachinanexperimentalmodelofcolorectalperitonealcarcinomatosis
AT sgarciagomezheras intraperitonealcollagenaseasanoveltherapeuticapproachinanexperimentalmodelofcolorectalperitonealcarcinomatosis
AT lvegaclemente intraperitonealcollagenaseasanoveltherapeuticapproachinanexperimentalmodelofcolorectalperitonealcarcinomatosis
AT solmedillaslopez intraperitonealcollagenaseasanoveltherapeuticapproachinanexperimentalmodelofcolorectalperitonealcarcinomatosis
AT hguadalajara intraperitonealcollagenaseasanoveltherapeuticapproachinanexperimentalmodelofcolorectalperitonealcarcinomatosis
AT mgarciaarranz intraperitonealcollagenaseasanoveltherapeuticapproachinanexperimentalmodelofcolorectalperitonealcarcinomatosis
_version_ 1718387322953662464